← FDA DRUG APPROVALS

FDA ANDA · ANDA078665

LEVONORGESTREL

Sponsor: FDN CONSUMER

APPLICATION
ANDA078665
TYPE
ANDA
ORIGINAL APPROVAL
2009-08-28
LATEST ACTION
2012-09-26
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

LEVONORGESTRELDiscontinued
LEVONORGESTREL 0.75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · TABLET · ORAL

Approval history

2012-09-26Labeling · Supplement 5AP
2010-09-01Labeling · Supplement 1AP
2009-08-28OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →